Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Bekker, Linda-Gail, Das, Moupali, Abdool Karim, Quarraisha, Ahmed, Khatija, Batting, Joanne, Brumskine, William, Gill, Katherine, Harkoo, Ishana, Jaggernath, Manjeetha, Kigozi, Godfrey, Kiwanuka, Noah, Kotze, Philip, Lebina, Limakatso, Louw, Cheryl E, Malahleha, Moelo, Manentsa, Mmatsie, Mansoor, Leila E, Moodley, Dhayendre, Naicker, Vimla, Naidoo, Logashvari, Naidoo, Megeshinee, Nair, Gonasagrie, Ndlovu, Nkosiphile, Palanee-Phillips, Thesla, Panchia, Ravindre, Pillay, Saresha, Potloane, Disebo, Selepe, Pearl, Singh, Nishanta, Singh, Yashna, Spooner, Elizabeth, Ward, Amy M, Zwane, Zwelethu, Ebrahimi, Ramin, Zhao, Yang, Kintu, Alexander, Deaton, Chris, Carter, Christoph C, Baeten, Jared M, Matovu Kiweewa, Flavia
Published in The New England journal of medicine (03.10.2024)
Published in The New England journal of medicine (03.10.2024)
Get more information
Journal Article